Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Translation of bi-directional transcripts enhances MHC-I peptide diversity

F. Zavadil, T. Henek, J. Habault, R. Chemali, MC. Tovar-Fernandez, C. Daskalogianni, L. Malbert-Colas, L. Wang, SV. Gnanasundram, B. Vojtesek, L. Hernychova, S. Apcher, R. Fahraeus

. 2025 ; 16 (-) : 1554561. [pub] 20250317

Language English

Document type Journal Article

Antisense transcripts play an important role in generating regulatory non-coding RNAs but whether these transcripts are also translated to generate functional peptides remains poorly understood. In this study, RNA sequencing and six-frame database generation were combined with mass spectrometry analysis of peptides isolated from polysomes to identify Nascent Pioneer Translation Products (Na-PTPs) originating from alternative reading frames of bi-directional transcripts. Two Na-PTP originating peptides derived from antisense strands stimulated CD8+ T cell proliferation when presented to peripheral blood mononuclear cells (PBMCs) from nine healthy donors. Importantly, an antigenic peptide derived from the reverse strand of two cDNA constructs was presented on MHC-I molecules and induced CD8+ T cell activation. The results demonstrate that three-frame translation of bi-directional transcripts generates antigenic peptide substrates for the immune system. This discovery holds significance for understanding the origin of self-discriminating peptide substrates for the major histocompatibility class I (MHC-I) pathway and for enhancing immune-based therapies against infected or transformed cells.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25016351
003      
CZ-PrNML
005      
20250731092842.0
007      
ta
008      
250708e20250317sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fimmu.2025.1554561 $2 doi
035    __
$a (PubMed)40165968
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a x
100    1_
$a Zavadil, Filip $u RECAMO, Masaryk Memorial Cancer Institute, Brno, Czechia
245    10
$a Translation of bi-directional transcripts enhances MHC-I peptide diversity / $c F. Zavadil, T. Henek, J. Habault, R. Chemali, MC. Tovar-Fernandez, C. Daskalogianni, L. Malbert-Colas, L. Wang, SV. Gnanasundram, B. Vojtesek, L. Hernychova, S. Apcher, R. Fahraeus
520    9_
$a Antisense transcripts play an important role in generating regulatory non-coding RNAs but whether these transcripts are also translated to generate functional peptides remains poorly understood. In this study, RNA sequencing and six-frame database generation were combined with mass spectrometry analysis of peptides isolated from polysomes to identify Nascent Pioneer Translation Products (Na-PTPs) originating from alternative reading frames of bi-directional transcripts. Two Na-PTP originating peptides derived from antisense strands stimulated CD8+ T cell proliferation when presented to peripheral blood mononuclear cells (PBMCs) from nine healthy donors. Importantly, an antigenic peptide derived from the reverse strand of two cDNA constructs was presented on MHC-I molecules and induced CD8+ T cell activation. The results demonstrate that three-frame translation of bi-directional transcripts generates antigenic peptide substrates for the immune system. This discovery holds significance for understanding the origin of self-discriminating peptide substrates for the major histocompatibility class I (MHC-I) pathway and for enhancing immune-based therapies against infected or transformed cells.
650    _2
$a lidé $7 D006801
650    12
$a MHC antigeny I. třídy $x imunologie $x genetika $7 D015395
650    12
$a CD8-pozitivní T-lymfocyty $x imunologie $7 D018414
650    12
$a peptidy $x imunologie $x genetika $7 D010455
650    12
$a proteosyntéza $7 D014176
650    _2
$a aktivace lymfocytů $x imunologie $7 D008213
650    _2
$a leukocyty mononukleární $x imunologie $7 D007963
650    _2
$a prezentace antigenu $7 D017951
650    12
$a antisense RNA $x genetika $x imunologie $7 D016372
655    _2
$a časopisecké články $7 D016428
700    1_
$a Henek, Tomas $u RECAMO, Masaryk Memorial Cancer Institute, Brno, Czechia
700    1_
$a Habault, Justine $u Inserm UMRS1131, Institut de Génétique Moléculaire, Université Paris Cité, Hôpital St. Louis, Paris, France
700    1_
$a Chemali, René $u UMR 1015 Immunologie des tumeurs et immunothérapie contre le cancer, B2M, Gustave Roussy, Université Paris Sud, Villejuif, France
700    1_
$a Tovar-Fernandez, Maria Camila $u Inserm UMRS1131, Institut de Génétique Moléculaire, Université Paris Cité, Hôpital St. Louis, Paris, France
700    1_
$a Daskalogianni, Chrysoula $u Inserm UMRS1131, Institut de Génétique Moléculaire, Université Paris Cité, Hôpital St. Louis, Paris, France
700    1_
$a Malbert-Colas, Laurence $u Inserm UMRS1131, Institut de Génétique Moléculaire, Université Paris Cité, Hôpital St. Louis, Paris, France
700    1_
$a Wang, Lixiao $u Department of Medical Biosciences, Umeå University, Umeå, Sweden
700    1_
$a Gnanasundram, Sivakumar Vadivel $u Department of Medical Biosciences, Umeå University, Umeå, Sweden
700    1_
$a Vojtesek, Borek $u RECAMO, Masaryk Memorial Cancer Institute, Brno, Czechia $u Laboratory of Growth Regulators, Institute of Experimental Botany, The Czech Academy of Sciences, Olomouc, Czechia
700    1_
$a Hernychova, Lenka $u RECAMO, Masaryk Memorial Cancer Institute, Brno, Czechia
700    1_
$a Apcher, Sebastien $u UMR 1015 Immunologie des tumeurs et immunothérapie contre le cancer, B2M, Gustave Roussy, Université Paris Sud, Villejuif, France
700    1_
$a Fahraeus, Robin $u RECAMO, Masaryk Memorial Cancer Institute, Brno, Czechia $u Inserm UMRS1131, Institut de Génétique Moléculaire, Université Paris Cité, Hôpital St. Louis, Paris, France $u UMR 1015 Immunologie des tumeurs et immunothérapie contre le cancer, B2M, Gustave Roussy, Université Paris Sud, Villejuif, France $u Department of Medical Biosciences, Umeå University, Umeå, Sweden $u Laboratory of Growth Regulators, Institute of Experimental Botany, The Czech Academy of Sciences, Olomouc, Czechia
773    0_
$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 16 (20250317), s. 1554561
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40165968 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731092836 $b ABA008
999    __
$a ok $b bmc $g 2366898 $s 1253476
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 16 $c - $d 1554561 $e 20250317 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
LZP    __
$a Pubmed-20250708

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...